Cargando…

Prevalence and determinants of language impairment in non‐demented amyotrophic lateral sclerosis patients

BACKGROUND AND PURPOSE: This study aimed at estimating the prevalence of language impairment (LI) in a large, clinic‐based cohort of non‐demented amyotrophic lateral sclerosis (ALS) patients and assessing its underpinnings at motor and non‐motor levels. METHODS: Non‐demented ALS patients (N = 348) u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solca, Federica, Aiello, Edoardo Nicolò, Torre, Silvia, Carelli, Laura, Ferrucci, Roberta, Verde, Federico, Ticozzi, Nicola, Silani, Vincenzo, Monti, Alessia, Poletti, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	ALS and frontotemporal dementia
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108014/ https://www.ncbi.nlm.nih.gov/pubmed/36445001 http://dx.doi.org/10.1111/ene.15652

Ejemplares similares

Amyotrophic lateral sclerosis: a clinical review
por: Masrori, P., et al.
Publicado: (2020)

Cortical inexcitability defines an adverse clinical profile in amyotrophic lateral sclerosis
por: Dharmadasa, T., et al.
Publicado: (2020)

Serum asymmetric dimethylarginine level correlates with the progression and prognosis of amyotrophic lateral sclerosis
por: Ikenaka, Kensuke, et al.
Publicado: (2022)

Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis
por: Falzone, Yuri Matteo, et al.
Publicado: (2022)

Social cognition deficits in amyotrophic lateral sclerosis: A pilot cross‐sectional population‐based study
por: Palumbo, Francesca, et al.
Publicado: (2022)

Respiratory onset of amyotrophic lateral sclerosis in a pregnant woman with a novel SOD1 mutation
por: Masrori, Pegah, et al.
Publicado: (2022)

Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis
por: Chang, Jeryn, et al.
Publicado: (2022)

Validity and diagnostics of the Reading the Mind in the Eyes Test (RMET) in non-demented amyotrophic lateral sclerosis (ALS) patients
por: Aiello, Edoardo Nicolò, et al.
Publicado: (2022)

Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double‐blind, placebo‐controlled trial
por: Beghi, Ettore, et al.
Publicado: (2022)

Feasibility and diagnostics of the Frontal Assessment Battery (FAB) in amyotrophic lateral sclerosis
por: Aiello, Edoardo Nicolò, et al.
Publicado: (2022)

Machine‐learning in motor neuron diseases: Prospects and pitfalls
por: Bede, Peter, et al.
Publicado: (2022)

Distinct disease trajectories in frontotemporal dementia–motor neuron disease and behavioural variant frontotemporal dementia: A longitudinal study
por: Long, Zhe, et al.
Publicado: (2022)

Mild behavioral impairment as a potential marker of predementia risk states in motor neuron diseases
por: Ferraro, Pilar M., et al.
Publicado: (2022)

Diagnostics and clinical usability of the Montreal Cognitive Assessment (MoCA) in amyotrophic lateral sclerosis
por: Aiello, Edoardo Nicolò, et al.
Publicado: (2022)

Semiology and determinants of apathy across neurodegenerative motor disorders: A comparison between amyotrophic lateral sclerosis, Parkinson’s and Huntington’s disease
por: Poletti, Barbara, et al.
Publicado: (2022)

Emotional Processing and Experience in Amyotrophic Lateral Sclerosis: A Systematic and Critical Review
por: Carelli, Laura, et al.
Publicado: (2021)

Diagnostic properties of the Italian ECAS Carer Interview (ECAS-CI)
por: Poletti, Barbara, et al.
Publicado: (2022)

Gaze-Contingent Eye-Tracking Training in Brain Disorders: A Systematic Review
por: Carelli, Laura, et al.
Publicado: (2022)

Bulbar involvement and cognitive features in amyotrophic lateral sclerosis: a retrospective study on 347 patients
por: Aiello, Edoardo Nicolò, et al.
Publicado: (2023)

Validity and diagnostics of the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson’s disease patients
por: D’Iorio, Alfonsina, et al.
Publicado: (2023)

Diagnostic properties of the Frontal Assessment Battery (FAB) in Huntington’s disease
por: Solca, Federica, et al.
Publicado: (2022)

Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis
por: Colombo, Eleonora, et al.
Publicado: (2022)

Correction to: Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis
por: Colombo, Eleonora, et al.
Publicado: (2023)

Primary progressive aphasia and motor neuron disease: A review
por: Aiello, Edoardo Nicolò, et al.
Publicado: (2022)

Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis
por: Verde, Federico, et al.
Publicado: (2023)

Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis
por: Verde, Federico, et al.
Publicado: (2022)

The Frontal Assessment Battery (FAB) effectively discriminates between MCI and dementia within the clinical spectrum of neurochemically confirmed Alzheimer’s disease
por: Aiello, Edoardo Nicolò, et al.
Publicado: (2022)

Tau physiology and pathomechanisms in frontotemporal lobar degeneration
por: Bodea, Liviu‐Gabriel, et al.
Publicado: (2016)

Prion‐like propagation as a pathogenic principle in frontotemporal dementia
por: Hock, Eva‐Maria, et al.
Publicado: (2016)

The use of P300-based BCIs in amyotrophic lateral sclerosis: from augmentative and alternative communication to cognitive assessment
por: Cipresso, Pietro, et al.
Publicado: (2012)

Is disrupted sleep a risk factor for Alzheimer’s disease? Evidence from a two-sample Mendelian randomization analysis
por: Anderson, Emma L, et al.
Publicado: (2020)

Association of Clinically Evident Eye Movement Abnormalities With Motor and Cognitive Features in Patients With Motor Neuron Disorders
por: Poletti, Barbara, et al.
Publicado: (2021)

Regional spreading pattern is associated with clinical phenotype in amyotrophic lateral sclerosis
por: Maranzano, Alessio, et al.
Publicado: (2023)

The Complex Interplay Between Depression/Anxiety and Executive Functioning: Insights From the ECAS in a Large ALS Population
por: Carelli, Laura, et al.
Publicado: (2018)

TMEM106B Acts as a Modifier of Cognitive and Motor Functions in Amyotrophic Lateral Sclerosis
por: Manini, Arianna, et al.
Publicado: (2022)

Human salivary Raman fingerprint as biomarker for the diagnosis of Amyotrophic Lateral Sclerosis
por: Carlomagno, C., et al.
Publicado: (2020)

Role of expectations in clinical outcomes after deep brain stimulation in patients with Parkinson’s disease: a systematic review
por: Mameli, Francesca, et al.
Publicado: (2023)

The impact of upper motor neuron involvement on clinical features, disease progression and prognosis in amyotrophic lateral sclerosis
por: Colombo, Eleonora, et al.
Publicado: (2023)

Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Verde, Federico, et al.
Publicado: (2021)

Relationship between Reaction Times and Post-COVID-19 Symptoms Assessed by a Web-Based Visual Detection Task
por: Maiorana, Natale Vincenzo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rkvpldvgsk65s4j1tr0b38r07u